Literature DB >> 31721374

Structural and positional studies of the antimicrobial peptide brevinin-1BYa in membrane-mimetic environments.

Patrick Brendan Timmons1, Donal O'Flynn2, J Michael Conlon3, Chandralal M Hewage1.   

Abstract

Brevinin-1BYa (FLPILASLAAKFGPKLFCLVTKKC), first isolated from skin secretions of the foothill yellow-legged frog Rana boylii, shows broad-spectrum activity, being particularly effective against opportunistic yeast pathogens. The structure of brevinin-1BYa was investigated in various solution and membrane-mimicking environments by proton nuclear magnetic resonance (1 H-NMR) spectroscopy and molecular modelling. The peptide does not possess a secondary structure in aqueous solution. In a 33% 2,2,2-trifluoroethanol (TFE-d3 )-H2 O solvent mixture, as well as in membrane-mimicking sodium dodecyl sulfate and dodecylphosphocholine micelles, the peptide's structure is characterised by a flexible helix-hinge-helix motif, with the hinge located at the Gly13 /Pro14 residues, and the two α-helices extending from Pro3 to Phe12 and from Pro14 to Thr21 . Positional studies involving the peptide in sodium dodecyl sulfate and dodecylphosphocholine micelles using 5-doxyl-labelled stearic acid and manganese chloride paramagnetic probes show that the peptide's helical segments lie parallel to the micellar surface, with the residues on the hydrophobic face of the amphipathic helices facing towards the micelle core and the hydrophilic residues pointing outwards, suggesting that the peptide exerts its biological activity by a non-pore-forming mechanism.
© 2019 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Keywords:  AMP; NMR; brevinin; modelling; peptides

Mesh:

Substances:

Year:  2019        PMID: 31721374     DOI: 10.1002/psc.3208

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  7 in total

1.  APPTEST is a novel protocol for the automatic prediction of peptide tertiary structures.

Authors:  Patrick Brendan Timmons; Chandralal M Hewage
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

2.  Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential.

Authors:  Yangyang Jiang; Yue Wu; Tao Wang; Xiaoling Chen; Mei Zhou; Chengbang Ma; Xinping Xi; Ying Zhang; Tianbao Chen; Chris Shaw; Lei Wang
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

3.  HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks.

Authors:  Patrick Brendan Timmons; Chandralal M Hewage
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

4.  Conformation and membrane interaction studies of the potent antimicrobial and anticancer peptide palustrin-Ca.

Authors:  Patrick B Timmons; Chandralal M Hewage
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

5.  Design, characterization and structure-function analysis of novel antimicrobial peptides based on the N-terminal CATH-2 fragment.

Authors:  Pratibha Sharma; Sheetal Sharma; Shubhi Joshi; Panchali Barman; Aashish Bhatt; Mayank Maan; Neha Singla; Praveen Rishi; Md Ehesan Ali; Simran Preet; Avneet Saini
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

6.  A Novel Amphibian Antimicrobial Peptide, Phylloseptin-PV1, Exhibits Effective Anti-staphylococcal Activity Without Inducing Either Hepatic or Renal Toxicity in Mice.

Authors:  Yue Liu; Daning Shi; Jin Wang; Xiaoling Chen; Mei Zhou; Xinping Xi; Jianming Cheng; Chengbang Ma; Tianbao Chen; Chris Shaw; Lei Wang
Journal:  Front Microbiol       Date:  2020-10-26       Impact factor: 5.640

Review 7.  The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides.

Authors:  Joanna Izabela Lachowicz; Kacper Szczepski; Alessandra Scano; Cinzia Casu; Sara Fais; Germano Orrù; Barbara Pisano; Monica Piras; Mariusz Jaremko
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.